XML 18 R7.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY - USD ($)
shares in Millions, $ in Millions
Total
Total Shareholders' Equity
Preferred Stock
Common Stock
APIC
AOCI
Retained Earnings
NCI
Balance, beginning of year (in shares) at Dec. 31, 2022     1 142        
Balance, beginning of year at Dec. 31, 2022 $ 1,996 $ 1,786 $ 0 $ 1 $ 1,254 $ (365) $ 896 $ 210
Increase (Decrease) in Shareholders' Equity                
Net earnings (loss) (130) (107)         (107) (23)
OCI 46 46       46    
Dividends on CPS $16.25 per share) (9) (9)         (9)  
Distributions to NCI, net of contributions 1             1
Other NCI transactions 2 2     2      
Stock-based plan activity (in shares)       1        
Stock-based plan activity 1 1     1      
Balance, end of year (in shares) at Mar. 31, 2023     1 143        
Balance, end of year at Mar. 31, 2023 1,907 1,719 $ 0 $ 1 1,257 (319) 780 188
Balance, beginning of year (in shares) at Dec. 31, 2022     1 142        
Balance, beginning of year at Dec. 31, 2022 1,996 1,786 $ 0 $ 1 1,254 (365) 896 210
Increase (Decrease) in Shareholders' Equity                
Net earnings (loss) 119              
OCI 37              
Balance, end of year (in shares) at Sep. 30, 2023     0 170        
Balance, end of year at Sep. 30, 2023 2,022 1,883 $ 0 $ 2 1,212 (331) 1,000 139
Balance, beginning of year (in shares) at Mar. 31, 2023     1 143        
Balance, beginning of year at Mar. 31, 2023 1,907 1,719 $ 0 $ 1 1,257 (319) 780 188
Increase (Decrease) in Shareholders' Equity                
Net earnings (loss) 68 61         61 7
OCI 17 17       17    
Dividends on CPS $16.25 per share) (10) (10)         (10)  
Distributions to NCI, net of contributions (26)             (26)
Other NCI transactions 6 2     2     4
Stock-based plan activity 8 8     8      
Balance, end of year (in shares) at Jun. 30, 2023     1 143        
Balance, end of year at Jun. 30, 2023 1,970 1,797 $ 0 $ 1 1,267 (302) 831 173
Increase (Decrease) in Shareholders' Equity                
Net earnings (loss) 181 206         206 (25)
OCI (26) (29)       (29)   3
Dividends on CPS $16.25 per share) (10) (10)         (10)  
Conversion of CPS to common stock (including make-whole payment) (in shares)     (1) 27        
Conversion of CPS to common stock (including make-whole payment) (26) (26)   $ 1     (27)  
Capped call transactions related to 2029 Notes (73) (73)     (73)      
Distributions to NCI, net of contributions (12)             (12)
Other NCI transactions 4 4     4      
Stock-based plan activity 14 14     14      
Balance, end of year (in shares) at Sep. 30, 2023     0 170        
Balance, end of year at Sep. 30, 2023 2,022 1,883 $ 0 $ 2 1,212 (331) 1,000 139
Balance, beginning of year (in shares) at Dec. 31, 2023       170        
Balance, beginning of year at Dec. 31, 2023 2,052 1,940   $ 2 1,228 (269) 979 112
Increase (Decrease) in Shareholders' Equity                
Net earnings (loss) 40 59         59 (19)
OCI (50) (50)       (50)    
Distributions to NCI, net of contributions (2)             (2)
Other NCI transactions 5 3     3     2
Stock-based plan activity (1) (1)   $ 1 (1)      
Balance, end of year (in shares) at Mar. 31, 2024       171        
Balance, end of year at Mar. 31, 2024 2,044 1,951   $ 2 1,230 (319) 1,038 93
Balance, beginning of year (in shares) at Dec. 31, 2023       170        
Balance, beginning of year at Dec. 31, 2023 2,052 1,940   $ 2 1,228 (269) 979 112
Increase (Decrease) in Shareholders' Equity                
Net earnings (loss) 219              
OCI (28)              
Balance, end of year (in shares) at Sep. 30, 2024       171        
Balance, end of year at Sep. 30, 2024 2,341 2,251   $ 2 1,286 (298) 1,261 90
Balance, beginning of year (in shares) at Mar. 31, 2024       171        
Balance, beginning of year at Mar. 31, 2024 2,044 1,951   $ 2 1,230 (319) 1,038 93
Increase (Decrease) in Shareholders' Equity                
Net earnings (loss) 153 169         169 (16)
OCI (8) (10)       (10)   2
Distributions to NCI, net of contributions 22             22
Other NCI transactions 23 23     23      
Stock-based plan activity 9 9     9   0  
Balance, end of year (in shares) at Jun. 30, 2024       171        
Balance, end of year at Jun. 30, 2024 2,243 2,142   $ 2 1,262 (329) 1,207 101
Increase (Decrease) in Shareholders' Equity                
Net earnings (loss) 25 54         54 (29)
OCI 31 31       31    
Distributions to NCI, net of contributions 16             16
Other NCI transactions 20 18     18     2
Stock-based plan activity 6 6     6      
Balance, end of year (in shares) at Sep. 30, 2024       171        
Balance, end of year at Sep. 30, 2024 $ 2,341 $ 2,251   $ 2 $ 1,286 $ (298) $ 1,261 $ 90